generated-image

Ultrabrief Pulsewidth Electroconvulsive Therapy (ECT) (UB ECT)
Mental Health 01 Jan 2013

Ultrabrief Pulsewidth Electroconvulsive Therapy (ECT) (UB ECT)

Electroconvulsive Therapy (ECT) remains essential to contemporary psychiatric practice and is one of the safest and most effective treatments available for depression.
Techniques to Improve Efficacy of Second Trimester Medical Termination
Research and Trials 01 Jan 2013

Techniques to Improve Efficacy of Second Trimester Medical Termination

Interruption of a pregnancy after 14 weeks gestation may be required when the foetus is dead, severely malformed or in cases of maternal illness.
Audit and Screening Study to Determine the Prevalence of Peripheral Arterial Disease (ACHILLES)
Research and Trials 01 Jan 2013

Audit and Screening Study to Determine the Prevalence of Peripheral Arterial Disease (ACHILLES)

The primary objective of the study is to establish the prevalence of lower extremity peripheral arterial disease in subjects with cardiovascular disease risk factors but no…
Safety and Efficacy Study of MPC-4326 for Treatment of Patients With HIV-1 Infection
Research and Trials 01 Jan 2013

Safety and Efficacy Study of MPC-4326 for Treatment of Patients With HIV-1 Infection

To evaluate the antiretroviral activity and safety of 200 mg BID and 300 mg BID doses of MPC-4326 administered as monotherapy for 14 days to…
A Study of Avastin (Bevacizumab) in Combination With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Glioblastoma
Cancer 01 Jan 2013

A Study of Avastin (Bevacizumab) in Combination With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Glioblastoma

This two-arm study will investigate the efficacy and safety of the addition of bevacizumab (Avastin) to the current standard of care (multimodality therapy of concurrent radiotherapy plus temozolomide followed by adjuvant temozolomide) as compared to the current standard of care alone. Patients will be randomly assigned to either the Avastin…
The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions
Research and Trials 01 Jan 2013

The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions

The purpose of this study is to evaluate the safety and effectiveness of the PROMUS ElementTM Everolimus-Eluting Coronary Stent System for the treatment of patients with up to 2 de novo atherosclerotic coronary artery lesions. Official Title PLATINUM: A Prospective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System…
Repeat Dose Safety Study for Compound to Treat Anaemia
Research and Trials 01 Jan 2013

Repeat Dose Safety Study for Compound to Treat Anaemia

The purpose of this study is to characterise the safety and tolerability of repeat doses of compound 1278863A in healthy subjects.
An Open Label Extension Study in Patients With Rheumatoid Arthritis
Research and Trials 01 Jan 2013

An Open Label Extension Study in Patients With Rheumatoid Arthritis

An Open Label Extension Study of Multiple Subcutaneous Doses of LY2127399 in Patients With Rheumatoid Arthritis
CyberKnife Radiosurgery for Organ-Confined Prostate Cancer: Homogenous Dose Distribution
Cancer 01 Jan 2013

CyberKnife Radiosurgery for Organ-Confined Prostate Cancer: Homogenous Dose Distribution

The purpose of this study is to determine the effects of CyberKnife radiosurgery in patients with early stage organ-confined prostate cancer. Official Title Prospective Evaluation of CyberKnife Stereotactic Radiosurgery for Low and Intermediate Risk Prostate Cancer: Homogenous Dose Distribution. Conditions Prostate Cancer Prostatic Cancer Prostate Neoplasms…